We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAD
10576
PUT
Teads Holding Co
TEAD
$66.8M
$202K ﹤0.01%
+40,100
New +$302K
LLAP
10577
CALL
DELISTED
Terran Orbital Corporation
LLAP
$202K ﹤0.01%
+44,100
New +$222K
AEHR icon
10578
CALL
Aehr Test Systems
AEHR
$4.37B
$201K ﹤0.01%
26,800
-152,800
-85% -$1.27M
EXK
10579
PUT
Endeavour Silver
EXK
$3.16B
$201K ﹤0.01%
63,900
-5,100
-7% -$20.1K
TUR icon
10580
iShares MSCI Turkey ETF
TUR
$222M
$201K ﹤0.01%
10,593
-9,759
-48% -$207K
EGIO
10581
PUT
DELISTED
Edgio, Inc. Common Stock
EGIO
$201K ﹤0.01%
2,178
-442
-17% -$63.6K
AEL
10582
PUT
DELISTED
American Equity Investment Life Holding Company
AEL
$201K ﹤0.01%
5,500
-1,600
-23% -$60.9K
BKSB
10583
DELISTED
BNY Mellon Short Duration Corporate Bond ETF
BKSB
$201K ﹤0.01%
4,245
-9,088
-68% -$434K
SQZ
10584
DELISTED
SQZ Biotechnologies Company
SQZ
$201K ﹤0.01%
63,241
+34,228
+118% +$123K
NX icon
10585
CALL
Quanex
NX
$962M
$200K ﹤0.01%
+8,800
New +$184K
VSH icon
10586
CALL
Vishay Intertechnology
VSH
$5.38B
$200K ﹤0.01%
11,200
-33,800
-75% -$642K
XWEL icon
10587
CALL
XWELL
XWEL
$8.28M
$200K ﹤0.01%
14,485
-4,510
-24% -$79.3K
YALA
10588
CALL
Yalla Group
YALA
$832M
$200K ﹤0.01%
51,400
+800
+2% +$3.15K
TRVN
10589
DELISTED
Trevena, Inc.
TRVN
$200K ﹤0.01%
774
+680
+723% +$150K
NXGN
10590
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$200K ﹤0.01%
+11,452
New +$218K
FBIO icon
10591
Fortress Biotech
FBIO
$97.7M
$199K ﹤0.01%
15,771
+4,868
+45% +$72.1K
HLLY icon
10592
Holley
HLLY
$377M
$199K ﹤0.01%
18,967
-20,675
-52% -$225K
INMB icon
10593
CALL
INmune Bio
INMB
$60.2M
$199K ﹤0.01%
22,500
-6,400
-22% -$47.6K
RFL icon
10594
Rafael Holdings
RFL
$103M
$199K ﹤0.01%
108,057
-38,841
-26% -$77.4K
VERX icon
10595
Vertex
VERX
$2.06B
$199K ﹤0.01%
17,581
-55,939
-76% -$707K
TAST
10596
DELISTED
Carrols Restaurant Group, Inc.
TAST
$199K ﹤0.01%
98,071
+36,101
+58% +$67.4K
SUNL
10597
CALL
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$199K ﹤0.01%
3,380
-2,165
-39% -$180K
CURI icon
10598
CuriosityStream
CURI
$211M
$198K ﹤0.01%
117,183
-8,153
-7% -$16.5K
CYH icon
10599
CALL
Community Health Systems
CYH
$423M
$198K ﹤0.01%
52,800
-70,400
-57% -$496K
FLN icon
10600
First Trust Latin America AlphaDEX Fund
FLN
$35.5M
$198K ﹤0.01%
12,120
-14,846
-55% -$282K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.